Northstar Advisory Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Northstar Advisory Group’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-16,729	Closed	-$1.39M	–	105
2022 Q4	$1.39M	Sell	16,729 -12,976	-44%	-$1.05M	1.1%	21
2022 Q3	$2.36M	Buy	29,705 +22,501	+312%	+$1.9M	2.11%	10
2022 Q2	$535K	Sell	7,204 -18,849	-72%	-$1.41M	0.4%	38
2022 Q1	$2.34M	Buy	+26,053	New	+$2.41M	1.51%	18

Other funds holding XBI

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Northstar Advisory Group's XBI Position: Q1 2023 in Review

Northstar Advisory Group sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2023, closing a stake of 16,729 shares — an estimated $1.39M sold.

Northstar Advisory Group first reported a position in XBI in Q1 2022 and held it in 4 quarters. The position peaked at $2.36M in Q3 2022. 713 funds tracked by Wall St. Rank hold XBI as of Q1 2023.

Northstar Advisory Group reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2023 after selling out during the quarter.
Northstar Advisory Group sold 16,729 State Street SPDR S&P Biotech ETF shares in Q1 2023, an estimated $1.39M.
Northstar Advisory Group first reported a position in State Street SPDR S&P Biotech ETF in Q1 2022 and held it in 4 quarters.
Northstar Advisory Group's State Street SPDR S&P Biotech ETF position peaked at $2.36M in Q3 2022.
713 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2023.

Based on Northstar Advisory Group's 13F filing for Q1 2023, filed 10 Apr 2023.